NAB-IT
Are you or someone you know experiencing agitation associated with Alzheimer’s disease?
We are conducting a new study to examine the safety and efficacy of nabilone for managing agitation in individuals with Alzheimer’s disease.
You may be eligible if you have a diagnosis of Alzheimer’s disease and are experiencing any of these symptoms:
- Feelings of irritability
- Restlessness, fidgeting and/or pacing
- Difficulty cooperating with others
- Frustration or anger
Participants must have a study partner who is available to participate with them.
For more information, please contact 416-480-6100 x63185 or email memoryresearch@sunnybrook.ca
